No profile data available.
Arcturus Therapeutics Holdings Inc. (ARCT) is a healthcare company in the antiviral pharmaceuticals industry, based in San Diego, United States, with about 106 full-time employees.
It reported revenue of $67.22 million for fiscal year 2025, down 51.4% from fiscal year 2024, and net income of -$65.78 million. Its market capitalization was $390.53 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system.
Arcturus Therapeutics reported $67.22 million in revenue for fiscal year 2025, down 51.4% from $138.39 million in fiscal year 2024.
$390.53 million as of October 9, 2026.
Listed companies of a similar size in the same industry (antiviral pharmaceuticals) include Valneva SE (VALN), Assembly Biosciences, Inc. (ASMB), Atea Pharmaceuticals, Inc. (AVIR), Agenus Inc. (AGEN).